Coya Therapeutics Inc. Revenue 2022–2025
Coya Therapeutics Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Coya Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 251147, a 2.61% decrease year-over-year.
- Coya Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 4.2 M, a 19.28% increase year-over-year.
- Coya Therapeutics Inc. annual revenue for 2025 was 7.9 M, a 123.57% increase from 2024.
- Coya Therapeutics Inc. annual revenue for 2024 was 3.6 M, a 40.79% decrease from 2023.
- Coya Therapeutics Inc. annual revenue for 2023 was 6.0 M.
- Coya Therapeutics Inc. annual revenue for 2022 was 0.
Coya Therapeutics Inc. (COYA) — Frequently Asked Questions
Coya Therapeutics Inc. (COYA) is a publicly traded US company. It has a market capitalization of $74M. In fiscal 2025 it reported revenue of $8M and net income of -$21M. Explore COYA's stock price, financial statements, earnings history, margins and key ratios below.
What is Coya Therapeutics Inc.'s market cap?
Coya Therapeutics Inc. (COYA) has a market capitalization of $74M.
What is the COYA stock price?
COYA trades at $4.41 (-1.56% on the day).
How much revenue does Coya Therapeutics Inc. make?
Coya Therapeutics Inc. reported revenue of $8M in fiscal 2025.
Is COYA profitable?
In fiscal 2025, Coya Therapeutics Inc. reported net income of -$21M.